Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 42

Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017” provides an overview of Fibrinogen Deficiency (Factor I Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company's product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufac......
$250

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products' manufacturers, and the federal gov......
$250

ArQule Inc (ARQL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including activated checkpoint therapy platform and c-met survival protein platform. Its lead product candidate, ARQ 197 (tivantinib), an inhibitor of the c-Met receptor tyrosine kinase, is undergoing clinical-stage development. The other product pipeline of the company includes ARQ 087 is a multi-kinase inhibitor, ARQ 092 is an Akt inhibitor, ARQ 751 is a next-generation inhibitor of Akt, ARQ 761 is an activator of the damage response pathway, , ARQ 531 is a B-cell malignancies and ARQ 087 is an inhibi......
$250

Novavax Inc (NVAX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccines using its proprietary recombinant nanoparticle vaccine technology including virus-like particle technology (VLPs) and matrix technology. Novavax's clinical product pipeline includes vaccines indicated against respiratory syncytial virus, influenza, Ebola virus, Zika virus and others. The company has a manufacturing facility in Gaithersburg, Maryland and a subsidiary (Novavax AB) in Sweden. Novavax is headquartered in Gaithersburg, Maryland, the US. Novavax Inc (NVAX) - Pharmaceuticals & He......
$250

Allergan Plc (AGN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women's health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered ......
$250

Anika Therapeutics Inc (ANIK) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products t......
$250

Intercept Pharmaceuticals Inc (ICPT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company's lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor. The company owns worldwide rights to OCA except for China, Japan and Korea, where the rights were exclusively licensed to Sumitomo Dainippon Pharma Co., Ltd., (Sumitomo Dainippon) along with an option to exclusively license OCA in certain other Asian countries. The product is also under development for the treatment of various other liver diseases. Intercept's other developmental products in pipeline include INT......
$250

Acerus Pharmaceuticals Corp (ASP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation, is a pharmaceutical company that develops, manufactures, markets and distributes innovative branded products. It focuses on men's and women's health. The company uses its proprietary drug delivery technology platforms, which include a bioadhesive nasal gel and the TriVair Deposition/Dispersion System, for the delivery of its products. Acerus's product portfolio includes Estrace, which is approved in Canada for relief from menopausal symptoms; Natesto, a testosterone nasal gel, which is approved by the US FDA for the treatment of male hypogonadism and filed for approval in Canada. Acerus is headquartered in Mississauga, Ontario, Canada. Acerus Pharmaceuticals Corp (ASP) - Pharmaceuticals & Healthcar......
$250

Ceapro Inc (CZO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and animals and cosmeceutical and nutraceutical industries. The company's portfolio include natural active ingredients comprising oat avenanthramides, oat oil, oat peptides, oat beta glucan, and lupin peptides; and veterinary products including oat shampoo, ear cleanser and dermal complex/conditioner. The company along with its subsidiaries operates mainly in the US, Germany, China, Canada and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada. Ceapro Inc (CZO) - Pharmaceuticals & ......
$250

Medline Industries Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, physician offices and other alternative care sites. The company offers products under various medical product categories including exam gloves, textiles, durable medical equipment, plastic patient utensils, skin care, disposable incontinence care, OR kits, protective apparel, gauze, packs and gowns, bathing systems, surgical trays and advanced wound care. The company markets products through its sales force and an established network of distribution centers in North America and across the world. ......
$250